Text Size
28 studies found for:    Open Studies | "Leishmaniasis"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Leishmaniasis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown † Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis
Conditions: Leishmaniasis;   Leishmaniasis, Mucocutaneous
Intervention: Drug: Miltefosine
2 Recruiting Low Antimonial Dosage in American Mucosal Leishmaniasis
Conditions: Mucosal Leishmaniasis;   Mucocutaneous Leishmaniasis
Intervention: Drug: Meglumine antimoniate
3 Recruiting Miltefosine to Treat Mucocutaneous Leishmaniasis
Conditions: Leishmaniasis, Mucocutaneous;   Cutaneous Leishmaniasis
Intervention: Drug: miltefosine
4 Available Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
Conditions: Leishmaniasis, Cutaneous;   Leishmaniasis, Mucocutaneous
Intervention: Drug: sodium stibogluconate (Pentostam)
5 Not yet recruiting SCH708980 With and Without AmBisome for Visceral Leishmaniasis
Conditions: Leishmaniasis;   Effects of Immunotherapy
Interventions: Drug: SCH708980 Anti-IL-10 monoclonal;   Drug: AmBisome
6 Recruiting Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: Pentoxifylline;   Drug: Placebo
7 Not yet recruiting Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: meglumine antimonate;   Drug: Placebo;   Drug: Pentoxifylline
8 Recruiting Comparison of Low and High Antimonial Dosage in American Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Intervention: Drug: Meglumine antimoniate
9 Recruiting Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: N-metil glucamine;   Drug: Azithromycin
10 Recruiting Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama
Condition: Cutaneous Leishmaniasis
Interventions: Drug: WR 279,396;   Drug: Paromomycin
11 Not yet recruiting Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention: Drug: AMBISOME
12 Recruiting Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil
Condition: Visceral Leishmaniasis
Interventions: Drug: Antimoniate of N-methylglucamine;   Drug: amphotericin B deoxycholate;   Drug: Liposomal amphotericin B
13 Unknown † Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine
Conditions: Visceral Leishmaniasis;   Immune Response;   Treatment
Interventions: Drug: N-acetylcysteine;   Drug: Pentavalent antimonial
14 Not yet recruiting Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia
Condition: Cutaneous Leishmaniasis
Intervention: Drug: Topical Amphotericin B at 3%
15 Recruiting Use of Sodium Stibogluconate as a Treatment for Leishmaniasis
Condition: Leishmaniasis
Intervention: Drug: Sodium Stibogluconate (SSG)
16 Recruiting Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis
Condition: Leishmaniasis, Cutaneous
Intervention: Drug: WR 279,396
17 Recruiting Phase III, Study of Three Short Course Combination Regimens (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome® Alone for the Treatment of Visceral Leishmaniasis in Bangladesh
Condition: Visceral Leishmaniasis
Interventions: Drug: Liposomal amphotericin B;   Drug: liposomal amphotericin B + miltefosine;   Drug: liposomal amphotericin B + paromomycin;   Drug: Miltefosine + Paromomycin
18 Unknown † Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa
Condition: Primary Visceral Leishmaniasis
Interventions: Drug: Liposomal amphotericin B (AmBisome®) and sodium stibogluconate;   Drug: Liposomal amphotericin B + miltefosine;   Drug: Miltefosine
19 Unknown † Pilot Study Using a Heat Pack to Treat Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Intervention: Device: Heat pack conduction-heat therapy
20 Recruiting Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study
Conditions: Visceral Leishmaniosis;   HIV-infection/Aids
Intervention: Drug: Pentamidine
To Top

Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results
† Indicates status has not been verified in more than two years